✨ Free AI Report
BeyondSpring Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research BeyondSpring Inc.
Company Research

BeyondSpring Inc.: Business Overview, Financials & Competitive Analysis

BeyondSpring Inc., a biopharmaceutical company, is dedicated to developing innovative cancer therapies to improve clinical outcomes for patients worldwide. Founded in 2010 and headquartered in New...

Analyst-debate audio for BeyondSpring Inc.

AskCyborg analysts argue the bull and bear cases for BeyondSpring Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Product Portfolio of BeyondSpring Inc.BeyondSpring Inc. Leadership and Management TeamFinancial Overview of BeyondSpring Inc.Marketing Strategies of BeyondSpring Inc.BeyondSpring Inc. Market Research and CompetitorsSales Strategies of BeyondSpring Inc.
Get Interactive Report Freeor start reading below
Live on AskCyborg
6/10Solid
BeyondSpring Inc.

Clinical validation in Phase 3 NSCLC trials provides near-term value inflection potential, but cash constraints require near-term financing solutions or regulatory success.

▶︎ Listen to the 90-second analyst debate
6/ 10Solid

Cyborg Score thesis

Clinical validation in Phase 3 NSCLC trials provides near-term value inflection potential, but cash constraints require near-term...

Read the full analyst-debate transcript →
Industry Biopharmaceutical/Oncology - Immuno-oncology and target protein degradation
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: August 17, 2026
AI-Verified Research
30+ Page Report

Get the Latest BeyondSpring Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

BeyondSpring Inc., a biopharmaceutical company, is dedicated to developing innovative cancer therapies to improve clinical outcomes for patients worldwide. Founded in 2010 and headquartered in New York, BeyondSpring Inc. focuses on advancing its robust pipeline of immuno-oncology therapies through cutting-edge science and strategic collaborations.

Product Portfolio of BeyondSpring Inc.

Pro stress-test →

BeyondSpring Inc. boasts an impressive product portfolio centered around Plinabulin, its lead asset. Plinabulin is a first-in-class agent that has shown promise in reducing chemotherapy-induced neutropenia and enhancing the efficacy of immune checkpoint inhibitors. The company is also exploring additional therapeutic indications for Plinabulin, including its use in combination therapies to treat various types of cancer.

BeyondSpring Inc. Leadership and Management Team

Pro stress-test →

The leadership and management team at BeyondSpring Inc. is composed of seasoned professionals with extensive experience in the biopharmaceutical industry. Dr. Lan Huang, Co-Founder and CEO, has a strong background in cancer research and drug development. The team is further strengthened by CFO and COO Dr. Richard Daly, who brings financial expertise and operational strategy to the company.

Financial Overview of BeyondSpring Inc.

Pro stress-test →

BeyondSpring Inc. operates with a solid financial foundation, driven by strategic funding rounds and partnerships. The company has demonstrated consistent growth in its financial metrics, with a focus on optimizing its capital structure to support ongoing research and development activities.

Marketing Strategies of BeyondSpring Inc.

BeyondSpring Inc. employs a multi-faceted marketing strategy that includes targeted outreach to oncologists, participation in key industry conferences, and leveraging digital platforms to enhance brand visibility. The company also collaborates with leading academic institutions and research organizations to bolster its marketing efforts.

BeyondSpring Inc. Market Research and Competitors

The competitive landscape for BeyondSpring Inc. includes major players in the biopharmaceutical industry, such as Amgen, Merck, and Bristol-Myers Squibb. The company differentiates itself through its innovative approach to cancer therapy, focusing on unmet medical needs and leveraging its proprietary technology platform.

Sales Strategies of BeyondSpring Inc.

BeyondSpring Inc. utilizes a combination of direct sales efforts and strategic partnerships to drive its sales initiatives. The company has established a strong presence in key markets, including the United States, Europe, and Asia, to maximize its reach and impact.

Technologies Utilized by BeyondSpring Inc.

BeyondSpring Inc. leverages state-of-the-art technologies in its drug development processes, including advanced genomics, bioinformatics, and machine learning algorithms. These technologies enable the company to accelerate the discovery and development of novel cancer therapies.

HR Practices at BeyondSpring Inc.

BeyondSpring Inc. is committed to fostering a diverse and inclusive workplace culture. The company invests in employee development through continuous learning programs, competitive compensation packages, and comprehensive health benefits. BeyondSpring Inc. also prioritizes employee well-being and work-life balance.

Corporate Responsibility Initiatives by BeyondSpring Inc.

BeyondSpring Inc. is dedicated to corporate social responsibility, with initiatives focused on supporting cancer research, patient advocacy, and community engagement. The company actively participates in philanthropic activities and collaborates with non-profit organizations to make a positive impact.

Future Plans of BeyondSpring Inc.

Looking ahead, BeyondSpring Inc. aims to expand its pipeline of innovative cancer therapies and advance its clinical trials. The company plans to explore new therapeutic areas, enhance its global footprint, and pursue strategic partnerships to accelerate its growth trajectory.

For a comprehensive and detailed analysis of BeyondSpring Inc., including in-depth market research, financial projections, and strategic insights, consider subscribing to our service at AskCyborg.com.


Get the full report on BeyondSpring Inc. by subscribing

What the analysts stress-tested

The top findings that survived the multi-agent debate for BeyondSpring Inc..

+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

Get alerted when BeyondSpring Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Pembrolizumab + ChemotherapyPD-1 checkpoint inhibitor with docetaxel for NSCLCNivolumab + IpilimumabDual checkpoint inhibitor combination for cancerDocetaxelStandard-of-care chemotherapy baseline

Compare BeyondSpring Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

BeyondSpring Inc. operates in Biopharmaceutical/Oncology - Immuno-oncology and target protein degradation. See how the rest of the sector scores on the Cyborg framework.

Browse Biopharmaceutical/Oncology - Immuno-oncology and target protein degradation research →
NEW · MCP server

Ask your AI assistant about BeyondSpring Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare BeyondSpring Inc. and its top competitor on Cyborg Score”
“What did BeyondSpring Inc. do this quarter?”
“Is BeyondSpring Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does BeyondSpring Inc. do?+
BeyondSpring Inc., a biopharmaceutical company, is dedicated to developing innovative cancer therapies to improve clinical outcomes for patients worldwide. Founded in 2010 and headquartered in New...
What is BeyondSpring Inc.'s Cyborg Score?+
BeyondSpring Inc. has a Cyborg Score of 6/10 (Solid). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are BeyondSpring Inc.'s main competitors?+
Named competitors include Pembrolizumab + Chemotherapy, Nivolumab + Ipilimumab, Docetaxel. The full competitive landscape is in the AskCyborg report.
How can I get the full BeyondSpring Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the BeyondSpring Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track BeyondSpring Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

More Company Research

Gambling and Lotteries Industry BriefingStationery and Office Products Industry BriefingDefense Tech Industry BriefingAi Infrastructure Systems Industry BriefingPet Insurance Industry BriefingSelf-Storage Industry BriefingMetal Additive Manufacturing Industry BriefingAi Accelerator Hardware Systems Industry BriefingLuxury Wines & Spirits Industry BriefingEnzymatic Plastic Recycling Industry BriefingInfrastructure as a Service (IaaS) Industry Briefingluxury fashion apparel Industry Briefing

Explore Industry Research

Travel Insurance Industry Company Research ReportSecurity Services Industry Company Research ReportLandscaping and Grounds Maintenance Industry Company Research ReportJanitorial and Cleaning Services Industry Company Research ReportSustainability Consulting Industry Company Research ReportReal Estate Investment Trusts (REITs) Industry Company Research Report
Browse All Company ResearchBrowse All Industry ResearchRSS Feed